These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 27166797)

  • 1. Obesity and Cardiovascular Risk: Variations in Visfatin Gene Can Modify the Obesity Associated Cardiovascular Risk. Results from the Segovia Population Based-Study. Spain.
    Martínez Larrad MT; Corbatón Anchuelo A; Fernández Pérez C; Pérez Barba M; Lazcano Redondo Y; Serrano Ríos M;
    PLoS One; 2016; 11(5):e0153976. PubMed ID: 27166797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Visfatin and its genetic variants are associated with obesity-related morbidities and cardiometabolic risk in severely obese children.
    Ooi SQ; Chan RM; Poh LK; Loke KY; Heng CK; Chan YH; Gan SU; Lee KO; Lee YS
    Pediatr Obes; 2014 Apr; 9(2):81-91. PubMed ID: 23447513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationship between circulating visfatin/nicotinamide phosphoribosyltransferase, obesity, inflammation and lipids profile in elderly population, determined by structural equation modeling.
    Owczarek AJ; Olszanecka-Glinianowicz M; Kocełak P; Bożentowicz-Wikarek M; Brzozowska A; Mossakowska M; Puzianowska-Kuźnicka M; Grodzicki T; Więcek A; Chudek J
    Scand J Clin Lab Invest; 2016 Dec; 76(8):632-640. PubMed ID: 27712122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic variation in the visfatin gene (PBEF1) and its relation to glucose metabolism and fat-depot-specific messenger ribonucleic acid expression in humans.
    Böttcher Y; Teupser D; Enigk B; Berndt J; Klöting N; Schön MR; Thiery J; Blüher M; Stumvoll M; Kovacs P
    J Clin Endocrinol Metab; 2006 Jul; 91(7):2725-31. PubMed ID: 16636125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of the + 45T>G adiponectin gene polymorphism with insulin resistance in non-diabetic Saudi women.
    Mackawy AM
    Gene; 2013 Nov; 530(1):158-63. PubMed ID: 23958652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of NAMPT haplotypes and metabolic risk factors on circulating visfatin/NAMPT levels in childhood obesity.
    Belo VA; Luizon MR; Lacchini R; Miranda JA; Lanna CM; Souza-Costa DC; Tanus-Santos JE
    Int J Obes (Lond); 2015 Jan; 39(1):130-5. PubMed ID: 24100423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Visfatin in obese children and adolescents and its association with insulin resistance and metabolic syndrome.
    Nourbakhsh M; Nourbakhsh M; Gholinejad Z; Razzaghy-Azar M
    Scand J Clin Lab Invest; 2015 Apr; 75(2):183-8. PubMed ID: 25723377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Visfatin/PBEF/Nampt and resistin expressions in circulating blood monocytes are differentially related to obesity and type 2 diabetes in humans.
    Laudes M; Oberhauser F; Schulte DM; Freude S; Bilkovski R; Mauer J; Rappl G; Abken H; Hahn M; Schulz O; Krone W
    Horm Metab Res; 2010 Apr; 42(4):268-73. PubMed ID: 20091460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The visfatin gene is associated with glucose and lipid metabolism in a Chinese population.
    Jian WX; Luo TH; Gu YY; Zhang HL; Zheng S; Dai M; Han JF; Zhao Y; Li G; Luo M
    Diabet Med; 2006 Sep; 23(9):967-73. PubMed ID: 16922702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Association between both resistin, visfatin and insulin resistance as well as β cell function in the first-degree relatives of type 2 diabetes mellitus].
    Zhang XJ; Wang Z; Li HH; Yu L; Gao S
    Zhonghua Liu Xing Bing Xue Za Zhi; 2010 Dec; 31(12):1393-6. PubMed ID: 21223671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Visfatin genotype may modify the insulin resistance and lipid profile in type 2 diabetes patients.
    Mirzaei K; Hossein-Nezhad A; Javad Hosseinzadeh-Attar M; Jafari N; Najmafshar A; Mohammadzadeh N; Larijani B
    Minerva Endocrinol; 2009 Dec; 34(4):273-9. PubMed ID: 20046156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum visfatin levels in a group of Egyptian obese individuals.
    Reda R; Shehab A; Soliman D; Gabr A; Abbass A
    Egypt J Immunol; 2011; 18(1):25-32. PubMed ID: 23082477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of circulating visfatin concentrations with insulin resistance and low-grade inflammation after dietary energy restriction in Spanish obese non-diabetic women: role of body composition changes.
    Agueda M; Lasa A; Simon E; Ares R; Larrarte E; Labayen I
    Nutr Metab Cardiovasc Dis; 2012 Mar; 22(3):208-14. PubMed ID: 20951014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The glutamine 27 glutamic acid polymorphism of the beta2-adrenoceptor gene is associated with abdominal obesity and greater risk of impaired glucose tolerance in men but not in women: a population-based study in Spain.
    González Sánchez JL; Proenza AM; Martínez Larrad MT; Ramis JM; Fernández Pérez C; Palou A; Serrano Ríos M
    Clin Endocrinol (Oxf); 2003 Oct; 59(4):476-81. PubMed ID: 14510910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of genetic variability in selected regions in visfatin (NAMPT) gene with anthropometric parameters and dietary composition in obese and non-obese Central-European population.
    Stastny J; Bienertova-Vasku J; Tomandl J; Tomandlova M; Zlamal F; Forejt M; Splichal Z; Vasku A
    Diabetes Metab Syndr; 2013; 7(3):166-71. PubMed ID: 23953183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Visfatin and SREBP-1c mRNA Expressions and Serum Levels Among Egyptian Women with Polycystic Ovary Syndrome.
    Abdul-Maksoud RS; Zidan HE; Saleh HS; Amer SA
    Genet Test Mol Biomarkers; 2020 Jul; 24(7):409-419. PubMed ID: 32460545
    [No Abstract]   [Full Text] [Related]  

  • 17. Dietary fat intake associated with bone mineral density among visfatin genotype in obese people.
    Khorrami-Nezhad L; Mirzaei K; Maghbooli Z; Keshavarz SA
    Br J Nutr; 2018 Jan; 119(1):3-11. PubMed ID: 29355093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated visfatin levels in obese children are related to proinflammatory factors.
    Li RZ; Ma Xn; Hu XF; Kang SX; Chen SK; Cianflone K; Lu HL
    J Pediatr Endocrinol Metab; 2013; 26(1-2):111-8. PubMed ID: 23327785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Visfatin in overweight/obesity, type 2 diabetes mellitus, insulin resistance, metabolic syndrome and cardiovascular diseases: a meta-analysis and systemic review.
    Chang YH; Chang DM; Lin KC; Shin SJ; Lee YJ
    Diabetes Metab Res Rev; 2011 Sep; 27(6):515-27. PubMed ID: 21484978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum visfatin levels in women with polycystic ovary syndrome.
    Güdücü N; İşçi H; Görmüş U; Yiğiter AB; Dünder I
    Gynecol Endocrinol; 2012 Aug; 28(8):619-23. PubMed ID: 22313145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.